Steven D. Nathan, MD, Maria L. Padilla, MD and Glenn D. Rosen, MD discuss the following:

  • Describe the 2010 CAPACITY trials. What were the study designs, results, and implications for clinical practice?

Upon completion of the activity, participants should be able to:

  • Discuss recent evidence of therapies used in the management of IPF

Access other Therapeutic Areas: